Robert J. Natuk

1.3k total citations
28 papers, 939 citations indexed

About

Robert J. Natuk is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Robert J. Natuk has authored 28 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 16 papers in Genetics and 12 papers in Immunology. Recurrent topics in Robert J. Natuk's work include Virus-based gene therapy research (16 papers), Herpesvirus Infections and Treatments (8 papers) and Immune Cell Function and Interaction (6 papers). Robert J. Natuk is often cited by papers focused on Virus-based gene therapy research (16 papers), Herpesvirus Infections and Treatments (8 papers) and Immune Cell Function and Interaction (6 papers). Robert J. Natuk collaborates with scholars based in United States, Canada and Netherlands. Robert J. Natuk's co-authors include Raymond M. Welsh, Michael D. Lubeck, Satoshi Mizutani, Bheem M. Bhat, Murty Chengalvala, Christine A. Biron, David Cooper, Min Guo, B B Mason and A. Davis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Robert J. Natuk

28 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Natuk United States 16 488 345 329 265 246 28 939
Michael Mackett United Kingdom 11 414 0.8× 282 0.8× 239 0.7× 148 0.6× 236 1.0× 13 779
W. Scott Gallichan Canada 13 486 1.0× 322 0.9× 698 2.1× 191 0.7× 159 0.6× 14 1.2k
C Pachl United States 18 922 1.9× 275 0.8× 265 0.8× 302 1.1× 414 1.7× 21 1.5k
Nicole Chenciner France 16 351 0.7× 154 0.4× 257 0.8× 266 1.0× 347 1.4× 27 886
Fernando de Noronha United States 14 288 0.6× 274 0.8× 211 0.6× 161 0.6× 217 0.9× 33 737
Kenichi Umene Japan 19 752 1.5× 179 0.5× 152 0.5× 193 0.7× 298 1.2× 61 1.1k
Paul P. Hung Canada 16 416 0.9× 313 0.9× 125 0.4× 305 1.2× 120 0.5× 30 857
Minoru Kidokoro Japan 15 273 0.6× 147 0.4× 419 1.3× 319 1.2× 175 0.7× 33 966
Nina F. Rose United States 12 642 1.3× 224 0.6× 300 0.9× 351 1.3× 434 1.8× 19 1.1k
M E Andrew Australia 16 293 0.6× 201 0.6× 438 1.3× 159 0.6× 109 0.4× 20 803

Countries citing papers authored by Robert J. Natuk

Since Specialization
Citations

This map shows the geographic impact of Robert J. Natuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Natuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Natuk more than expected).

Fields of papers citing papers by Robert J. Natuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Natuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Natuk. The network helps show where Robert J. Natuk may publish in the future.

Co-authorship network of co-authors of Robert J. Natuk

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Natuk. A scholar is included among the top collaborators of Robert J. Natuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Natuk. Robert J. Natuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Glesby, Marshall J., Wendy Watson, Cynthia Brinson, et al.. (2014). Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine. The Journal of Infectious Diseases. 212(1). 18–27. 43 indexed citations
3.
Visalli, Robert J., et al.. (2014). Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models. Vaccine. 32(12). 1398–1406. 13 indexed citations
4.
Johnson, J. Erik, John W. Coleman, Narender K. Kalyan, et al.. (2009). In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation. Vaccine. 27(22). 2930–2939. 21 indexed citations
5.
Kowalski, Jacek, Karissa Adkins, Heather Arendt, et al.. (2006). Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. Vaccine. 25(12). 2296–2305. 8 indexed citations
6.
Cooper, David A., Min Guo, Farooq Nasar, et al.. (2006). Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction. Cellular Immunology. 239(2). 113–120. 10 indexed citations
7.
Clarke, David K., Farooq Nasar, Margaret Lee, et al.. (2006). Synergistic Attenuation of Vesicular Stomatitis Virus by Combination of Specific G Gene Truncations and N Gene Translocations. Journal of Virology. 81(4). 2056–2064. 73 indexed citations
8.
Zolla‐Pazner, Susan, Michael D. Lubeck, Serena Xu, et al.. (1998). Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees. Journal of Virology. 72(2). 1052–1059. 58 indexed citations
9.
Lubeck, Michael D., Robert J. Natuk, Murty Chengalvala, et al.. (1994). Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal Administration. AIDS Research and Human Retroviruses. 10(11). 1443–1449. 64 indexed citations
10.
Natuk, Robert J., Michael D. Lubeck, Pranab K. Chanda, et al.. (1993). Immunogenicity of Recombinant Human Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees. AIDS Research and Human Retroviruses. 9(5). 395–404. 56 indexed citations
11.
Natuk, Robert J., P K Chanda, Michael D. Lubeck, et al.. (1992). Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model.. Proceedings of the National Academy of Sciences. 89(16). 7777–7781. 45 indexed citations
12.
Chengalvala, Murty, Michael D. Lubeck, Robert J. Natuk, et al.. (1991). Adenovirus vectors for gene expression. Current Opinion in Biotechnology. 2(5). 718–722. 14 indexed citations
13.
Chanda, Pranab K., Robert J. Natuk, Surendra K. Dheer, et al.. (1990). Helper Independent Recombinant Adenovirus Vectors: Expression of HIV env or HBV Surface Antigen. International Reviews of Immunology. 7(1). 67–77. 6 indexed citations
14.
15.
Hung, P.P., P K Chanda, Robert J. Natuk, et al.. (1990). Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccines.. PubMed. 9(3). 160–4. 5 indexed citations
16.
Natuk, Robert J., Jack F. Bukowski, J O Brubaker, & Raymond M. Welsh. (1989). Antiviral effect of lymphokine-activated killer cells: chemotaxis and homing to sites of virus infection. Journal of Virology. 63(11). 4969–4971. 6 indexed citations
17.
Lubeck, Michael D., A. Davis, Murty Chengalvala, et al.. (1989). Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.. Proceedings of the National Academy of Sciences. 86(17). 6763–6767. 122 indexed citations
18.
McIntyre, Kim W., Robert J. Natuk, Christine A. Biron, et al.. (1988). Blastogenesis of Large Granular Lymphocytes in Nonlymphoid Organs. Journal of Leukocyte Biology. 43(6). 492–501. 15 indexed citations
19.
Natuk, Robert J. & Raymond M. Welsh. (1987). Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication.. The Journal of Immunology. 138(3). 877–883. 85 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Mackett Breakdown of academic impact, for papers by W. Scott Gallichan Breakdown of academic impact, for papers by C Pachl Breakdown of academic impact, for papers by Nicole Chenciner Breakdown of academic impact, for papers by Fernando de Noronha Breakdown of academic impact, for papers by Kenichi Umene Breakdown of academic impact, for papers by Paul P. Hung Breakdown of academic impact, for papers by Minoru Kidokoro Breakdown of academic impact, for papers by Nina F. Rose Breakdown of academic impact, for papers by M E Andrew
Rankless by CCL
2026